A new synthetic approach to benzo[4’,5’]imidazo[2’,1’:6,1]pyrido[2,3-d]pyrimidine was developed using 2,4,6-trisubstituted pyrimidinyl-5-propanoic acids, overcoming limitations of previous benzimidazole-based methods. This strategy enables functional modifications and enhances biological research potential.